Completed
Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation
NCT00630435
- Conditions
- Menopause
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying Menopause. Study availability and eligibility vary by location and protocol.
NCT00630435
Not specified
NCT00110565
NCT00283231
NCT00355953
Not specified
NCT00464789
Not specified
NCT00165204
NCT00064831
NCT00564031
NCT00066144
NCT00369434